Summary
- Current Price
- As of today, LH price is $331.66, up +1.24% on
- Current Price All-Time High
- LH price is currently -2.97% below its historical high of $341.80 set on
- Market Cap
- LH current market cap is $27B, up +18.51% over the past 365 days
- PE Ratio
- LH current PE ratio is 27.43
- Revenue
- LH current annual revenue is $13.95B, up +7.25% year-over-year
- Next Earnings
- The next earnings release for LH is on
Profile
| Metric | Value |
|---|---|
| Full Name | Labcorp Holdings Inc. |
| Ticker | NYSE: LH |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | |
| Website | labcorp.com |
| Employees | 70,000 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $331.66 | |
| Price, 1D Change | +1.24% | |
| Market Cap | $27B | |
| TTM Dividend Yield | 0.87% | |
| PE Ratio | 27.43 | |
| Beta | 0.29 | |
| Revenue | $13.95B | |
| Revenue, 1Y Change | +7.25% | |
| EPS | $10.46 | |
| EPS, 1Y Change | +18.33% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.72 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 291:250 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $10.46 | |
| EPS Estimate | $18.35 | N/A |
| EPS Est. Change | +75.40% | N/A |
| Revenue | $13.95B | |
| Revenue Estimate | $14.75B | N/A |
| Revenue Est. Change | +5.72% | N/A |
| Current Price | $331.66 | |
| Price Target | $350.00 | - |
| Price Tgt. Change | +5.53% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $14.52 | $8.84 | -39.13% | |
| $16.33 | $10.46 | -35.94% | |
| $18.35 | N/A | +75.40% | |
| $19.80 | N/A | +89.29% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $12.98B | $13.01B | +0.24% | |
| $13.99B | $13.95B | -0.29% | |
| $14.75B | N/A | +5.72% | |
| $15.47B | N/A | +10.91% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +21.14% | |
| Price, 3Y | +60.55% | |
| Market Cap, 1Y | +18.51% | |
| Market Cap, 3Y | +46.79% | |
| Revenue, 1Y | +7.25% | |
| Revenue, 3Y | +17.60% | |
| EPS, 1Y | +18.33% | |
| EPS, 3Y | -25.10% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $331.66 | |
| SMA 200 | $274.92 | |
| SMA 50 | $304.00 | |
| EMA 200 | $280.41 | |
| EMA 50 | $308.66 | |
| MACD | $8.51 | |
| Beta | 0.29 | |
| ATR | $7.54 | |
| 14-Day RSI | 61.91 | |
| 10-Day Volatility | 14.64% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.72 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 0.87% | |
| Total Dividend | $2.88 | |
| $240.70M | ||
| 27.42% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $13.95B | |
| EPS | $10.46 | |
| Gross Profit | $3.73B | |
| Gross Margin | 26.75% | |
| Operating Income | $1.52B | |
| Operating Margin | 10.87% | |
| Net Income | $877.70M | |
| Net Margin | 6.29% | |
| EBITDA | $2.20B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.76 | |
| 1.42 | ||
| 1.23 | ||
| - | ||
| 7 | ||
| 3.42 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 27.43 | |
| 1.87 | ||
| 3.13 | ||
| 14.42 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $8.62B | |
| $532.30M | ||
| $18.39B | ||
| $4.02B | ||
| $9.76B | ||
| $2.82B | ||
| Total Debt | $6.52B | |
| $691.20M | ||
| $840.80M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $13.08B | ||
| $2.22B | ||
| $10.22B | ||
| $0.00 | ||
| $681.10M | ||
| $0.00 | ||
| $229.80M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $1.64B | ||
| -$1.19B | ||
| -$1.46B | ||
| Capex | $434.50M | |
| $1.21B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Piper Sandler | → | |
| JP Morgan | → | |
| Truist Securities | → | |
| Morgan Stanley | → | |
| Barclays | → | |
| B of A Securities | → | |
| Baird | → | |
| Evercore ISI Group | → | |
| Piper Sandler | → | |
| JP Morgan | → |
Analyst sentiment
Institutional ownership
Screeners with LH
FAQ
- What is the ticker symbol for Labcorp Holdings Inc.?
- The ticker symbol for Labcorp Holdings Inc. is NYSE:LH
- Does Labcorp Holdings Inc. pay dividends?
- Yes, Labcorp Holdings Inc. pays dividends. The last payment was $0.72, with an ex-dividend date on August 28, 2026
- What sector is Labcorp Holdings Inc. in?
- Labcorp Holdings Inc. is in the Healthcare sector
- What industry is Labcorp Holdings Inc. in?
- Labcorp Holdings Inc. is in the Diagnostics & Research industry
- What country is Labcorp Holdings Inc. based in?
- Labcorp Holdings Inc. is headquartered in United States
- When did Labcorp Holdings Inc. go public?
- Labcorp Holdings Inc. initial public offering (IPO) was on March 29, 1990
- Is Labcorp Holdings Inc. in the S&P 500?
- Yes, Labcorp Holdings Inc. is included in the S&P 500 index
- Is Labcorp Holdings Inc. in the NASDAQ 100?
- No, Labcorp Holdings Inc. is not included in the NASDAQ 100 index
- Is Labcorp Holdings Inc. in the Dow Jones?
- No, Labcorp Holdings Inc. is not included in the Dow Jones index
- When was Labcorp Holdings Inc. last earnings report?
- Labcorp Holdings Inc.'s most recent earnings report was on July 30, 2026
- When does Labcorp Holdings Inc. report earnings?
- The next expected earnings date for Labcorp Holdings Inc. is November 3, 2026
Data Sources & References
- LH Official Website www.labcorp.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/920148/000092014826000111/0000920148-26-000111-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- LH Profile on Yahoo Finance finance.yahoo.com/quote/LH
- LH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lh
